Small Cell Lung Carcinoma Extensive Disease
4 clinical trials · Condition
◉ Watch Small Cell Lung Carcinoma Extensive Disease
| Record | Firm | Date |
|---|---|---|
| Durvalumab Plus Chemotherapy in Untreated Patients With Extensive-Stage Small Cell Lung Cancer (NCT04712903) | AstraZeneca | 2020-12-16 |
| Durvalumab Plus Chemotherapy in ES-SCLC (Oriental) (NCT04449861) | AstraZeneca | 2020-12-07 |
| Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN) (NCT03043872) | AstraZeneca | 2017-03-27 |
| Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer (NCT00658580) | European Lung Cancer Working Party | 2000-04-01 |
Track Small Cell Lung Carcinoma Extensive Disease automatically
Every clearance here is in the API, with alerts when new ones post.